Guideline for the pharmacological treatment of hypertension in adults

Guideline for the pharmacological treatment of hypertension in adults

Bibliographic Details
Main Author: World Health Organization (issuing body)
Corporate Author: World Health Organization, issuing body (issuing body)
Format: eBook
Language:Inglés
Published: Geneva : World Health Organization [2021]
Edition:1st ed
Subjects:
Hypertension.
See on Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009632232706719
Table of Contents:
  • Intro
  • Acknowledgements
  • Acronyms and abbreviations
  • Executive summary
  • 1 Introduction
  • 2 Method for developing the guideline
  • 2.1 Guideline contributors
  • 2.2 Analytical framework and PICOs
  • 2.3 Outcome importance rating
  • 2.4 Reviews of evidence
  • 2.5 Certainty of evidence and strength of recommendations
  • 2.6 Deciding upon recommendations
  • 2.7 Funding
  • 3 Recommendations
  • 3.1 Blood pressure threshold for initiation of pharmacological treatment
  • 3.2 Laboratory testing before and during pharmacological treatment
  • 3.3 Cardiovascular disease risk assessment as guide to initiation of antihypertensive medications
  • 3.4 Drug classes to be used as first-line agents
  • 3.5 Combination therapy
  • 3.6 Target blood pressure
  • 3.7 Frequency of re-assessment
  • 3.8 Administration of treatment by nonphysician professionals
  • 4 Special settings
  • 4.1 Hypertension in disaster, humanitarian and emergency settings
  • 4.2 COVID-19 and hypertension
  • 4.3 Pregnancy and hypertension
  • 5 Publication, implementation, evaluation and research gaps
  • 5.1 Publication
  • 5.2 Implementation and dissemination
  • 5.3 Evaluation
  • 5.4 Future updating of the guideline
  • 5.5 Research gaps
  • 6 Implementation tools
  • 6.1 Guideline recommendations
  • 6.2 Drug- and dose-specific protocols
  • References
  • Annex 1: List of contributors
  • Annex 2. Managing declarations of interest and conflicts of interest
  • Annex 3: Treatment outcomes relevant to hypertension
  • Annex 4: PICO questions
  • Fig. 1 Analytic framework for antihypertensive medication treatment
  • Fig. 2 Framework for analysis
  • Fig. 3 An approach for starting treatment with a single-pill combination
  • Fig. 4 An approach for starting treatment not using a single-pill combination (i.e. with monotherapy or free combination therapy)
  • Fig. 5 Algorithm 1
  • Fig. 6 Algorithm 2.
  • Fig. A3.1 Rating of outcomes
  • _GoBack.

Similar Items